Title : Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation.

Pub. Date : 2021 Oct 6

PMID : 33992804






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate (MVA) pathway for the cholesterol biosynthesis. Mevalonic Acid 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
2 Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate (MVA) pathway for the cholesterol biosynthesis. Mevalonic Acid 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
3 Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate (MVA) pathway for the cholesterol biosynthesis. Mevalonic Acid 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
4 Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate (MVA) pathway for the cholesterol biosynthesis. Mevalonic Acid 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens